BRIEF published on 04/29/2024 at 09:17, 2 years 6 months ago Bet-at-home.com AG Fiscal Year 2023 Financial Results and Market Outlook Financial Results Market Outlook Bet-at-home.com AG Legal Challenges UEFA EURO Championship
BRIEF published on 04/29/2024 at 09:17, 2 years 6 months ago Bet-at-home.com AG Résultats financiers et perspectives de marché pour l'exercice 2023 Résultats Financiers Perspectives Du Marché Bet-at-home.com AG Défis Juridiques Championnat D'Europe De L'UEFA
PRESS RELEASE published on 04/29/2024 at 09:12, 2 years 6 months ago Original-Research: bet-at-home.com AG (von NuWays AG): Halten bet-at-home.com AG reported final FY23 figures in line with prelims, showing solid performance. Analyst recommendation: Halten. Risks from indicative decision in Germany may impact stock Analyst Recommendation FY23 Figures Bet-at-home.com AG Germany Decision Stock Risks
BRIEF published on 03/07/2024 at 09:07, 2 years 8 months ago Bet-at-home.com AG maintient une position stable avec des prévisions mises à jour pour l'exercice 24 Étude De Marché Conseils Financiers NuWays SA Bet-at-home.com AG BAIIA
BRIEF published on 03/07/2024 at 09:07, 2 years 8 months ago Bet-at-home.com AG Maintains Stable Position with Updated FY24 Guidance EBITDA Financial Guidance NuWays AG Market Research Bet-at-home.com AG
PRESS RELEASE published on 03/07/2024 at 09:02, 2 years 8 months ago Original-Research: bet-at-home.com AG (von NuWays AG): HOLD bet-at-home.com AG reported solid FY23 prelims and introduced FY24 guidance in line with estimates. Sales met expectations, EBITDA on target. Efficiency measures expected to drive growth in FY24 despite risks EBITDA FY24 Guidance FY23 Prelims Bet-at-home.com AG Efficiency Measures
BRIEF published on 03/06/2024 at 10:05, 2 years 8 months ago Bet-at-Home.com AG publie ses résultats pour l'exercice 2023 Résultats Financiers Perspectives 2024 Réorientation Stratégique Bet-at-home.com AG Performances 2023
BRIEF published on 03/06/2024 at 10:05, 2 years 8 months ago Bet-at-Home.com AG Reports Financial Year 2023 Results Financial Results 2023 Performance 2024 Outlook Strategic Reorientation Bet-at-home.com AG
PRESS RELEASE published on 03/06/2024 at 10:00, 2 years 8 months ago bet-at-home.com AG: group company figures for 2023 (01.01.2023 until 31.12.2023) bet-at-home.com AG announces its full-year 2023 IFRS financial results, highlighting revenue & earnings performance. Strategic transformation and outlook for 2024 also provided Financial Results Revenue Earnings Strategic Transformation Bet-at-home.com AG
BRIEF published on 03/05/2024 at 15:46, 2 years 8 months ago Bet-at-home.com AG Reports FY 2023 Financials and Forecasts for FY 2024 Financial Results Gaming Industry FY 2023 Bet-at-home.com AG Forecast FY 2024
Published on 11/06/2026 at 22:15, 2 days 11 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 09:00, 30 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 09:00, 31 minutes ago Municipality Finance issues a GBP 50 million tap under its MTN programme
Published on 11/09/2026 at 09:00, 31 minutes ago Municipality Finance issues EUR 47.5 million zero coupon notes under its MTN programme
Published on 11/09/2026 at 09:00, 31 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 11/09/2026 at 07:00, 2 hours 31 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 31 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 31 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 31 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
